1 C. López-Otín, M.A. Blasco, L. Partridge, et al.The hallmarks of aging Cell, 153 (6) (2013), pp. 1194-1217

2 A. Bajpai, R. Li, W. ChenThe cellular mechanobiology of aging: from biology to mechanics Ann N Y Acad Sci, 1491 (1) (2021), pp. 3-24

3 M.H. YunChanges in regenerative capacity through lifespan Int J Mol Sci, 16 (10) (2015), pp. 25392-25432

4 J. CampisiAging, cellular senescence, and cancer Annu Rev Physiol, 75 (2013), pp. 685-705

5 L. Partridge, J. Deelen, P.E. SlagboomFacing up to the global challenges of ageing Nature, 561 (7721) (2018), pp. 45-56

6 A. Chandra, J. RajawatSkeletal aging and osteoporosis: mechanisms and therapeutics Int J Mol Sci, 22 (7) (2021), p. 3553

7 X. Fu, G. Liu, A. Halim, et al.Mesenchymal stem cell migration and tissue repair Cells, 8 (8) (2019), p. 784

8 V. Turinetto, E. Vitale, C. GiachinoSenescence in human mesenchymal stem cells: functional changes and implications in stem cell-based therapy Int J Mol Sci, 17 (7) (2016), p. 1164

9 N. Baker, L.B. Boyette, R.S. TuanCharacterization of bone marrow-derived mesenchymal stem cells in aging Bone, 70 (2015), pp. 37-47

10 J.C. Sepúlveda, M. Tomé, M.E. Fernández, et al.Cell senescence abrogates the therapeutic potential of human mesenchymal stem cells in the lethal endotoxemia model Stem Cell, 32 (7) (2014), pp. 1865-1877

11 R. Ren, A. Ocampo, G.H. Liu, et al.Regulation of stem cell aging by metabolism and epigenetics Cell Metabol, 26 (3) (2017), pp. 460-474

12 N.M. Al Aboud, C. Tupper, I. JialalGenetics, Epigenetic Mechanism StatPearls Publishing, Treasure Island (FL) (2022)

13 B.J. Morris, B.J. Willcox, T.A. DonlonGenetic and epigenetic regulation of human aging and longevity Biochim Biophys Acta BBA Mol Basis Dis, 1865 (7) (2019), pp. 1718-1744

14 Y. Wang, Q. Yuan, L. XieHistone modifications in aging: the underlying mechanisms and implications Curr Stem Cell Res Ther, 13 (2) (2018), pp. 125-135

15 E.M. Horwitz, K. Le Blanc, M. Dominici, et al.Clarification of the nomenclature for MSC: the international society for cellular therapy position statement Cytotherapy, 7 (5) (2005), pp. 393-395

16 M. Dominici, K. Le Blanc, I. Mueller, et al.Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement Cytotherapy, 8 (4) (2006), pp. 315-317

17 R.M. Samsonraj, M. Raghunath, V. Nurcombe, et al.Concise review: multifaceted characterization of human mesenchymal stem cells for use in regenerative medicine Stem Cells Transl Med, 6 (12) (2017), pp. 2173-2185

18 A. Andrzejewska, B. Lukomska, M. JanowskiConcise review: mesenchymal stem cells: from roots to boost Stem Cell, 37 (7) (2019), pp. 855-864

19 H. Kupcova SkalnikovaProteomic techniques for characterisation of mesenchymal stem cell secretome Biochimie, 95 (12) (2013), pp. 2196-2211

20 M. Krampera, J. Galipeau, Y. Shi, et al.Immunological characterization of multipotent mesenchymal stromal cells—the International Society for Cellular Therapy (ISCT) working proposal Cytotherapy, 15 (9) (2013), pp. 1054-1061

21 B.K. Kennedy, S.L. Berger, A. Brunet, et al.Geroscience: linking aging to chronic disease Cell, 159 (4) (2014), pp. 709-713

22 X. Tian, A. Seluanov, V. GorbunovaMolecular mechanisms determining lifespan in short- and long-lived species Trends Endocrinol Metabol, 28 (10) (2017), pp. 722-734

23 A. Stolzing, E. Jones, D. McGonagle, et al.Age-related changes in human bone marrow-derived mesenchymal stem cells: consequences for cell therapies Mech Ageing Dev, 129 (3) (2008), pp. 163-173

24 S. Zhou, J.S. Greenberger, M.W. Epperly, et al.Age-related intrinsic changes in human bone-marrow-derived mesenchymal stem cells and their differentiation to osteoblasts Aging Cell, 7 (3) (2008), pp. 335-343

25 M. Rhinn, B. Ritschka, W.M. KeyesCellular senescence in development, regeneration and disease Development, 146 (20) (2019), p. dev151837

26 A. Wilson, L.A. Shehadeh, H. Yu, et al.Age-related molecular genetic changes of murine bone marrow mesenchymal stem cells BMC Genom, 11 (2010), p. 229

27 X. Chen, L. Wang, J. Hou, et al.Study on the dynamic biological characteristics of human bone marrow mesenchymal stem cell senescence Stem Cell Int, 2019 (2019), Article 9271595

28 Y. Ma, M. Qi, Y. An, et al.Autophagy controls mesenchymal stem cell properties and senescence during bone aging Aging Cell, 17 (2018), Article e12709

29 D. Cakouros, S. GronthosThe changing epigenetic landscape of Mesenchymal Stem/Stromal Cells during aging Bone, 137 (2020), Article 115440

30 C. Sidler, R. Woycicki, D. Li, et al.A role for SUV39H1-mediated H3K9 trimethylation in the control of genome stability and senescence in WI38 human diploid lung fibroblasts Aging, 6 (7) (2014), pp. 545-563

31 E.G. Pasyukova, A.V. Symonenko, O.Y. Rybina, et al.Epigenetic enzymes: a role in aging and prospects for pharmacological targeting Ageing Res Rev, 67 (2021), Article 101312

32 M.R. Choi, Y.H. In, J. Park, et al.Genome-scale DNA methylation pattern profiling of human bone marrow mesenchymal stem cells in long-term culture Exp Mol Med, 44 (8) (2012), pp. 503-512

33 T. Squillaro, V. Severino, N. Alessio, et al.De-regulated expression of the BRG1 chromatin remodeling factor in bone marrow mesenchymal stromal cells induces senescence associated with the silencing of NANOG and changes in the levels of chromatin proteins Cell Cycle, 14 (8) (2015), pp. 1315-1326

34 M. Pu, Z. Ni, M. Wang, et al.Trimethylation of Lys36 on H3 restricts gene expression change during aging and impacts life span Genes Dev, 29 (7) (2015), pp. 718-731

35 Y. Li, L. Fan, J. Hu, et al.MiR-26a rescues bone regeneration deficiency of mesenchymal stem cells derived from osteoporotic mice Mol Ther, 23 (8) (2015), pp. 1349-1357

36 B. Li, J. Zhao, J.X. Ma, et al.Overexpression of DNMT1 leads to hypermethylation of H19 promoter and inhibition of Erk signaling pathway in disuse osteoporosis Bone, 111 (2018), pp. 82-91

37 D.V. Fyodorov, B.R. Zhou, A.I. Skoultchi, et al.Emerging roles of linker histones in regulating chromatin structure and function Nat Rev Mol Cell Biol, 19 (3) (2018), pp. 192-206

38 Y. Zhang, Z. Sun, J. Jia, et al.Overview of histone modification Adv Exp Med Biol, 1283 (2021), pp. 1-16

39 A.J. Bannister, T. KouzaridesRegulation of chromatin by histone modifications Cell Res, 21 (3) (2011), pp. 381-395

40 A. Barski, S. Cuddapah, K. Cui, et al.High-resolution profiling of histone methylations in the human genome Cell, 129 (4) (2007), pp. 823-837

41 L. Ye, Z. Fan, B. Yu, et al.Histone demethylases KDM4B and KDM6B promotes osteogenic differentiation of human MSCs Cell Stem Cell, 11 (1) (2012), pp. 50-61

42 H. Jing, L. Liao, Y. An, et al.Suppression of EZH2 prevents the shift of osteoporotic MSC fate to adipocyte and enhances bone formation during osteoporosis Mol Ther, 24 (2) (2016), pp. 217-229

43 D. Cakouros, S. Isenmann, L. Cooper, et al.Twist-1 induces Ezh2 recruitment regulating histone methylation along the Ink4A/Arf locus in mesenchymal stem cells Mol Cell Biol, 32 (8) (2012), pp. 1433-1441

44 C. Li, Y. Chai, L. Wang, et al.Programmed cell senescence in skeleton during late puberty Nat Commun, 8 (2017), p. 1312

45 R. Duan, W. Du, W. GuoEZH2:a novel target for cancer treatment J Hematol Oncol, 13 (2020), p. 104

46 S. Hemming, D. Cakouros, S. Isenmann, et al.EZH2 and KDM6A act as an epigenetic switch to regulate mesenchymal stem cell lineage specification Stem Cell, 32 (3) (2014), pp. 802-815

47 S. Hong, Y.W. Cho, L.R. Yu, et al.Identification of JmjC domain-containing UTX and JMJD3 as histone H3 lysine 27 demethylases Proc Natl Acad Sci U S A, 104 (47) (2007), pp. 18439-18444

48 P. Deng, Q. Yuan, Y. Cheng, et al.Loss of KDM4B exacerbates bone-fat imbalance and mesenchymal stromal cell exhaustion in skeletal aging Cell Stem Cell, 28 (6) (2021), pp. 1057-1073.e7

49 C. Wilson, A.J. KriegKDM4B: a nail for every hammer? Genes, 10 (2) (2019), p. 134

50 J. Tan, H. Huang, W. Huang, et al.The genomic landscapes of histone H3-Lys9 modifications of gene promoter regions and expression profiles in human bone marrow mesenchymal stem cells J Genet Genom, 35 (10) (2008), pp. 585-593

51 C. Wang, J. Wang, J. Li, et al.KDM5A controls bone morphogenic protein 2-induced osteogenic differentiation of bone mesenchymal stem cells during osteoporosis Cell Death Dis, 7 (8) (2016), p. e2335

52 M. Afarideh, R. Thaler, F. Khani, et al.Global epigenetic alterations of mesenchymal stem cells in obesity: the role of vitamin C reprogramming Epigenetics, 16 (7) (2021), pp. 705-717

53 R. Kirtana, Manna, S.K. PatraMolecular mechanisms of KDM5A in cellular functions: facets during development and disease Exp Cell Res, 396 (2) (2020), Article 112314

54 B. Yin, F. Yu, C. Wang, et al.Epigenetic control of mesenchymal stem cell fate decision via histone methyltransferase Ash1l Stem Cell, 37 (1) (2019), pp. 115-127

55 X.J. Sun, J. Wei, X.Y. Wu, et al.Identification and characterization of a novel human histone H3 lysine 36-specific methyltransferase J Biol Chem, 280 (42) (2005), pp. 35261-35271

56 L. Wang, N. Niu, L. Li, et al.H3K36 trimethylation mediated by SETD2 regulates the fate of bone marrow mesenchymal stem cells PLoS Biol, 16 (11) (2018), Article e2006522

57 J. Wysocka, C.D. Allis, S. CoonrodHistone arginine methylation and its dynamic regulation Front Biosci, 11 (2006), pp. 344-355

58 Z. Xu, W. Wu, F. Shen, et al.Histone arginine methylation-mediated epigenetic regulation of discoidin domain receptor 2 controls the senescence of human bone marrow mesenchymal stem cells Stem Cell Int, 2019 (2019), Article 7670316

59 Y. Zhu, X. Song, F. Han, et al.Alteration of histone acetylation pattern during long-term serum-free culture conditions of human fetal placental mesenchymal stem cells PLoS One, 10 (2) (2015), Article e0117068

60 J.W. Jung, S. Lee, M.S. Seo, et al.Histone deacetylase controls adult stem cell aging by balancing the expression of polycomb genes and jumonji domain containing 3 Cell Mol Life Sci, 67 (7) (2010), pp. 1165-1176

61 S. Lee, J.R. Park, M.S. Seo, et al.Histone deacetylase inhibitors decrease proliferation potential and multilineage differentiation capability of human mesenchymal stem cells Cell Prolif, 42 (6) (2009), pp. 711-720

62 L. Zhang, M. Qi, J. Chen, et al.Impaired autophagy triggered by HDAC9 in mesenchymal stem cells accelerates bone mass loss Stem Cell Res Ther, 11 (2020), p. 269

63 N. Suka, Y. Suka, A.A. Carmen, et al.Highly specific antibodies determine histone acetylation site usage in yeast heterochromatin and euchromatin Mol Cell, 8 (2) (2001), pp. 473-479

64 P. Zhang, Y. Liu, C. Jin, et al.Histone acetyltransferase GCN5 regulates osteogenic differentiation of mesenchymal stem cells by inhibiting NF-κB J Bone Miner Res, 31 (2) (2016), pp. 391-402

65 H. Jing, X. Su, B. Gao, et al.Epigenetic inhibition of Wnt pathway suppresses osteogenic differentiation of BMSCs during osteoporosis Cell Death Dis, 9 (2) (2018), p. 176

66 J.E. Herrera, M. Bergel, X.J. Yang, et al.The histone acetyltransferase activity of human GCN5 and PCAF is stabilized by coenzymes J Biol Chem, 272 (43) (1997), pp. 27253-27258

67 P. Zhang, Y. Liu, C. Jin, et al.Histone H3K9 acetyltransferase PCAF is essential for osteogenic differentiation through bone morphogenetic protein signaling and may be involved in osteoporosis Stem Cell, 34 (9) (2016), pp. 2332-2341

68 Z. Li, C. Liu, Z. Xie, et al.Epigenetic dysregulation in mesenchymal stem cell aging and spontaneous differentiation PLoS One, 6 (6) (2011), Article e20526

69 G. Liu, H. Chen, H. Liu, et al.Emerging roles of SIRT6 in human diseases and its modulators Med Res Rev, 41 (2) (2021), pp. 1089-1137

70 H. Pan, D. Guan, X. Liu, et al.SIRT6 safeguards human mesenchymal stem cells from oxidative stress by coactivating NRF2 Cell Res, 26 (2) (2016), pp. 190-205

71 A.R. Killaars, C.J. Walker, K.S. AnsethNuclear mechanosensing controls MSC osteogenic potential through HDAC epigenetic remodeling Proc Natl Acad Sci U S A, 117 (35) (2020), pp. 21258-21266

72 Y.H. Chen, C.C. Chung, Y.C. Liu, et al.Enhancer of zeste homolog 2 and histone deacetylase 9c regulate age-dependent mesenchymal stem cell differentiation into osteoblasts and adipocytes Stem Cell, 34 (8) (2016), pp. 2183-2193

73 S. Isenmann, A. Arthur, A.C.W. Zannettino, et al.TWIST family of basic helix-loop-helix transcription factors mediate human mesenchymal stem cell growth and commitment Stem Cell, 27 (10) (2009), pp. 2457-2468

74 R. Yang, J. Chen, J. Zhang, et al.1, 25-Dihydroxyvitamin D protects against age-related osteoporosis by a novel VDR-Ezh2-p16 signal axis Aging Cell, 19 (2) (2020), Article e13095

75 X. Han, N. Zhu, Y. Wang, et al.1, 25(OH)2D3 inhibits osteogenic differentiation through activating β-catenin signaling via downregulating bone morphogenetic protein 2 Mol Med Rep, 22 (6) (2020), pp. 5023-5032

76 Y.N. Qu, L. Zhang, T. Wang, et al.Vitamin C treatment rescues prelamin A-induced premature senescence of subchondral bone mesenchymal stem cells Stem Cell Int, 2020 (2020), Article 3150716

77 L. Lv, W. Ge, Y. Liu, et al.Lysine-specific demethylase 1 inhibitor rescues the osteogenic ability of mesenchymal stem cells under osteoporotic conditions by modulating H3K4 methylation Bone Res, 4 (2016), Article 16037

78 Y. Liang, X. Liu, R. Zhou, et al.Chaetocin promotes osteogenic differentiation via modulating Wnt/beta-catenin signaling in mesenchymal stem cells Stem Cell Int, 2021 (2021), Article 8888416

79 Y. Fu, P. Zhang, J. Ge, et al.Histone deacetylase 8 suppresses osteogenic differentiation of bone marrow stromal cells by inhibiting histone H3K9 acetylation and RUNX2 activity Int J Biochem Cell Biol, 54 (2014), pp. 68-77

80 Y. Wang, T. Chen, H. Yan, et al.Role of histone deacetylase inhibitors in the aging of human umbilical cord mesenchymal stem cells J Cell Biochem, 114 (10) (2013), pp. 2231-2239

81 M. Nie, Y. Wang, Z. Yu, et al.AURKB promotes gastric cancer progression via activation of CCND1 expression Aging, 12 (2) (2020), pp. 1304-1321

82 S. Oh, T. Suganuma, M.M. Gogol, et al.Histone H3 threonine 11 phosphorylation by Sch9 and CK2 regulates chronological lifespan by controlling the nutritional stress response Elife, 7 (2018), Article e36157

83 A. Schellenberg, Q. Lin, H. Schüler, et al.Replicative senescence of mesenchymal stem cells causes DNA-methylation changes which correlate with repressive histone marks Aging, 3 (9) (2011), pp. 873-888

84 C. Zhou, J. Zou, S. Zou, et al.INO80 is required for osteogenic differentiation of human mesenchymal stem cells Sci Rep, 6 (2016), Article 35924

85 S.M. HoyTazemetostat: first approval Drugs, 80 (5) (2020), pp. 513-521

86 P. Campbell, C.M. ThomasBelinostat for the treatment of relapsed or refractory peripheral T-cell lymphoma J Oncol Pharm Pract, 23 (2) (2017), pp. 143-147

87 H. Heers, J. Stanislaw, J. Harrelson, et al.Valproic acid as an adjunctive therapeutic agent for the treatment of breast cancer Eur J Pharmacol, 835 (2018), pp. 61-74